Status:
COMPLETED
Impact of Herniation on WFNS Grading in Spontaneous Subarachnoid Hemorrhage - a SWISS SOS Observational Trial
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Subarachnoid Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
All patients (≥18 years) with a spontaneous SAH proven by computed tomography (CT), magnetic resonance imaging (MRI) or lumbar puncture will be considered for this trial. Upon presentation to a neuros...
Detailed Description
Background Aneurysmal subarachnoid hemorrhage (SAH) is a severe disease affecting approximately 400 patients per year in Switzerland. Death and severe disability after spontaneous SAH are related to ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Written informed consent of the patient or consent of patient's next of kin
- Spontaneous SAH
- Age: ≥18
- Glasgow coma scale (GCS) ≤ 12. In intubated patients the GCS assessment will be performed after cessation of sedation or if not possible the last GCS score before intubation will be used
- Exclusion Criteria
- SAH due to any other cause or structural abnormality of the brain (trauma, dissection, arterio-venous malformation, dural arterio-venous fistula)
- Foreseeable difficulties in follow-up due to geographic reasons (e.g., patients living abroad)
Exclusion
Key Trial Info
Start Date :
December 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2020
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT02304328
Start Date
December 1 2015
End Date
August 1 2020
Last Update
September 3 2020
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Kantonsspital Aarau
Aarau, Switzerland, 5001
2
University Hospital Basel
Basel, Switzerland, 4031
3
Department of Neurosurgery, University Hospital Bern
Bern, Switzerland, 3010
4
Hôpitaux Universitaires de Genève
Geneva, Switzerland, 1211